Clara Vila-Castelar1,2, Kathryn V Papp2,3,4, Rebecca E Amariglio2,3,4, Valeria L Torres5, Ana Baena6, Diana Gomez6, Jorge Rendon6, Aubryn Samaroo4, Francisco Lopera6, Dorene M Rentz2,3,4, Yakeel T Quiroz1,2,4,6. 1. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA. 2. Harvard Medical School, Boston, MA, USA. 3. Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA. 4. Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. 5. Department of Psychology, Florida Atlantic University, Boca Raton, FL, USA. 6. Grupo de Neurociencias de Antioquia, Universidad de Antioquia, Medellín, Colombia.
Abstract
OBJECTIVE: The Face-Name Associative Memory Exam (FNAME) has been used to detect subtle cognitive changes in clinically normal older adults at increased risk for Alzheimer's disease. FNAME assesses learning and delayed recall for face-name pairs. The aim of this study is to introduce a Latin American Spanish version of the FNAME (LAS-FNAME), examine its psychometric properties, and provide preliminary normative data in a sample of clinically normal, Spanish-speaking individuals from Antioquia, Colombia. METHOD: 59 clinically-normal individuals (71% females) were recruited by the Grupo de Neurociencias in Antioquia (Colombia). Age ranged from 27 to 82 years (M = 50.31, SD = 15.32) and years of education ranged from 2 to 17 years (M = 9.02, SD = 4.11). All participants completed the LAS-FNAME and a brief neuropsychological evaluation. We examined associations between age, education, and sex and performance on the LAS-FNAME. Internal consistency, convergent and discriminant validity were also assessed. Test-restest reliability was computed for a subset of participants (n = 32). RESULTS: LAS-FNAME exhibited moderate convergent validity with other memory measures (Free and Cued Selective Reminding Scale, r s=.465, p<.01; Wechsler Memory Scale III - Logical Memory Delayed Recall, r s=.479, p<.01). The subscales of the LAS-FNAME exhibited adequate internal consistency (α=.825). Test-retest reliability analyses demonstrated consistency of scores over time. Normative data was stratified by age (<50, 50-65, >65) and low and high educational attainment (≤8 and >8 years of education, respectively). CONCLUSIONS: The LAS-FNAME is a valid and reliable measure to assess memory in clinically normal, Spanish-speaking individuals from Colombia for clinical and research purposes.
OBJECTIVE: The Face-Name Associative Memory Exam (FNAME) has been used to detect subtle cognitive changes in clinically normal older adults at increased risk for Alzheimer's disease. FNAME assesses learning and delayed recall for face-name pairs. The aim of this study is to introduce a Latin American Spanish version of the FNAME (LAS-FNAME), examine its psychometric properties, and provide preliminary normative data in a sample of clinically normal, Spanish-speaking individuals from Antioquia, Colombia. METHOD: 59 clinically-normal individuals (71% females) were recruited by the Grupo de Neurociencias in Antioquia (Colombia). Age ranged from 27 to 82 years (M = 50.31, SD = 15.32) and years of education ranged from 2 to 17 years (M = 9.02, SD = 4.11). All participants completed the LAS-FNAME and a brief neuropsychological evaluation. We examined associations between age, education, and sex and performance on the LAS-FNAME. Internal consistency, convergent and discriminant validity were also assessed. Test-restest reliability was computed for a subset of participants (n = 32). RESULTS:LAS-FNAME exhibited moderate convergent validity with other memory measures (Free and Cued Selective Reminding Scale, r s=.465, p<.01; Wechsler Memory Scale III - Logical Memory Delayed Recall, r s=.479, p<.01). The subscales of the LAS-FNAME exhibited adequate internal consistency (α=.825). Test-retest reliability analyses demonstrated consistency of scores over time. Normative data was stratified by age (<50, 50-65, >65) and low and high educational attainment (≤8 and >8 years of education, respectively). CONCLUSIONS: The LAS-FNAME is a valid and reliable measure to assess memory in clinically normal, Spanish-speaking individuals from Colombia for clinical and research purposes.
Entities:
Keywords:
Associative memory; Spanish; test development
Authors: Reisa Sperling; Elizabeth Chua; Andrew Cocchiarella; Erin Rand-Giovannetti; Russell Poldrack; Daniel L Schacter; Marilyn Albert Journal: Neuroimage Date: 2003-10 Impact factor: 6.556
Authors: Daniel Camilo Aguirre-Acevedo; Fabian Jaimes-Barragán; Eliana Henao; Victoria Tirado; Claudia Muñoz; Eric M Reiman; Pierre N Tariot; Jessica B Langbaum; Francisco Lopera Journal: Int Psychogeriatr Date: 2015-10-19 Impact factor: 3.878
Authors: Elizabeth Rose Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer Journal: Alzheimers Dement Date: 2016-02-11 Impact factor: 21.566
Authors: Saul L Miller; Kim Celone; Kristina DePeau; Eli Diamond; Bradford C Dickerson; Dorene Rentz; Maija Pihlajamäki; Reisa A Sperling Journal: Proc Natl Acad Sci U S A Date: 2008-01-31 Impact factor: 11.205
Authors: Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling Journal: J Neurosci Date: 2006-10-04 Impact factor: 6.167
Authors: J L O'Brien; K M O'Keefe; P S LaViolette; A N DeLuca; D Blacker; B C Dickerson; R A Sperling Journal: Neurology Date: 2010-05-12 Impact factor: 9.910
Authors: Reisa A Sperling; Dorene M Rentz; Keith A Johnson; Jason Karlawish; Michael Donohue; David P Salmon; Paul Aisen Journal: Sci Transl Med Date: 2014-03-19 Impact factor: 17.956
Authors: Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling Journal: Alzheimers Dement Date: 2018-04 Impact factor: 21.566
Authors: Aubryn Samaroo; Rebecca E Amariglio; Samantha Burnham; Paige Sparks; Michael Properzi; Aaron P Schultz; Rachel Buckley; Keith A Johnson; Reisa A Sperling; Dorene M Rentz; Kathryn V Papp Journal: Alzheimers Dement (Amst) Date: 2021-01-05
Authors: Clara Vila-Castelar; Nathalia Muñoz; Kathryn V Papp; Rebecca E Amariglio; Ana Baena; Edmarie Guzmán-Vélez; Yamile Bocanegra; Justin S Sanchez; Eric M Reiman; Keith A Johnson; Reisa A Sperling; Francisco Lopera; Dorene M Rentz; Yakeel T Quiroz Journal: Alzheimers Res Ther Date: 2020-09-10 Impact factor: 6.982